Trial Profile
Effects of fampridine in multiple sclerosis patients with walking disability on gait parameters
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 22 Feb 2016 New trial record